Received Apr 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
was sick and after dose 1 of Shingrix; did not feel well; This non-serious case was reported by a nurse via sales rep and described the occurrence of sickness in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced sickness (Verbatim: was sick and after dose 1 of Shingrix) and feeling unwell (Verbatim: did not feel well). The outcome of the sickness and feeling unwell were not reported. It was unknown if the reporter considered the sickness and feeling unwell to be related to Shingrix. It was unknown if the company considered the sickness and feeling unwell to be related to Shingrix. Additional Information: GSK Receipt Date: 01-APR-2025 The patient had been vaccinated with Shingrix. The patient was sick and did not feel well after dose 1 of Shingrix. She did get the 2nd dose of Shingrix vaccine. It is unknown if that dose also made her feel bad.